Advanced Medical Solutions Group Plc: Scheme of Arrangement Hearing Listed
Advanced Medical Solutions Group Plc (company number 02867684) appears on the Insolvency and Companies Court cause list for a scheme of arrangement hearing under Part 26 of the Companies Act 2006. Scheduled for 17 July 2026, the remote hearing will address a court-sanctioned compromise or arrangement between the AIM-listed medical technology manufacturer and its shareholders or creditors.
Hearing details
| Date | Time | Court | Case Number | Case Type |
| :--- | :--- | :--- | :--- | :--- |
| 17 July 2026 | 10:30am | Insolvency and Companies Court | CR-2026-004993 | Scheme of Arrangement |
Corporate profile
Incorporated in November 1993, Advanced Medical Solutions Group Plc develops and manufactures tissue-healing technologies, including surgical glues and wound care dressings. The business operates globally under brands such as LiquiBand and Resorba.
According to the Companies House register, the active entity maintains its registered office at Premier Park, Winsford Industrial Estate, Cheshire. For the financial period ending 25 March 2026, the company reported a turnover of £177.5 million with an unqualified auditor's opinion and an estimated workforce of 1,600 employees.
Expert analysis: Interpreting a Part 26 scheme
Schemes of arrangement are sophisticated statutory mechanisms. For a publicly traded entity, a Part 26 scheme is frequently utilised to execute a solvent corporate action, such as a recommended takeover, a demerger, or an internal group reorganisation.
Professionals must distinguish a traditional Part 26 scheme from a Part 26A Restructuring Plan. The latter was introduced specifically to assist companies in financial distress and includes cross-class cram-down provisions. A standard Part 26 scheme requires the approval of a statutory majority (a majority in number representing 75% in value) of each affected class of creditors or members, followed by the final sanction of the court.
Because Advanced Medical Solutions Group Plc is traded on the AIM market, the primary source of context for this hearing will be its regulatory disclosures. Counterparties should review the Regulatory News Service (RNS) feed to confirm whether this scheme relates to an acquisition, a return of capital, or a structural realignment.
Composite worked example
Consider a scenario where a major logistics supplier holds a long-term contract with a Plc undergoing a scheme of arrangement for an acquisition. The supplier receives a scheme document outlining the proposed change of control.
The supplier's credit team must determine if the acquiring entity has a weaker credit profile than the current parent company. If the scheme alters the corporate structure, the supplier may need to negotiate a new parent company guarantee or adjust their credit limits before the court sanctions the scheme and makes it legally binding on all creditors.
Counterparty due diligence checklist
For suppliers, lenders, and counterparties, a scheme of arrangement requires immediate review to assess any impact on commercial rights or security.
1. Review regulatory announcements: Check the London Stock Exchange RNS feed for the explanatory statement detailing the commercial rationale of the scheme.
2. Assess security interests: If the scheme involves debt refinancing, conduct a company charge check to verify if new fixed or floating charges are being registered over the company's assets.
3. Verify absence of hostile action: Even during solvent reorganisations, credit managers should run a winding up petition search to confirm no concurrent hostile actions have been filed by unconnected creditors.
4. Evaluate contract change-of-control clauses: Determine whether the court-sanctioned arrangement triggers any termination rights or requires contract novation.
Traditional monitoring vs Corp Intel
Maintaining a defensible audit trail of counterparty risk traditionally requires manual effort. Professionals typically check the HMCTS e-Filing portal for cause list updates, search the Companies House filing history for structural changes, and monitor The Gazette for statutory notices. This fragmented approach creates a delay between a legal event occurring and the credit team taking action.
Corp Intel automates this intelligence gathering. By aggregating court lists, statutory registers, and insolvency notices into a single timeline, professionals can monitor a UK company free and receive immediate alerts when a scheme convening hearing, petition, or new charge is published. This ensures advisory and credit teams are positioned to act proactively rather than reacting to outdated information.
***
Disclaimer: This report summarises entries on the published court cause list. Presentation of a scheme application or petition is not a determination of insolvency; the outcome is a matter for the court. Companies believing they are named incorrectly should email contact@corp-intel.co.uk.